FDA Inspection 1211246 — Zhejiang Jiangbei Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Jiangbei Pharmaceutical Co., Ltd. on July 7, 2023 in Taizhou City. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 7, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taizhou City (China)